Pathology Slide Review in Vulvar Cancer Does Not Change Patient Management

por Beugeling, Maaike, Ewing-Graham, Patricia C., Mzallassi, Zineb, van Doorn, Helena C.
Publicado 2014

Collaboration Benefits All

por Hemida, Reda A., van Doorn, Helena C., Massuger, Leon F.A.G.
Publicado 2020

Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years

por Buis, Christien C.M, van Doorn, Helena C, Dinjens, Winand N.M, Ewing, Patricia C
Publicado 2010

Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study

por Nieuwenhuyzen-de Boer, Gatske M., Kengsakul, Malika, Boere, Ingrid A., van Doorn, Helena C., van Beekhuizen, Heleen J.
Publicado 2022

Differentiated vulvar intraepithelial neoplasia (dVIN): the most helpful histological features and the utility of cytokeratins 13 and 17

por Dasgupta, Shatavisha, Ewing-Graham, Patricia C., van Kemenade, Folkert J., van Doorn, Helena C., Noordhoek Hegt, Vincent, Koljenović, Senada
Publicado 2018

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A.M., van Doorn, Helena C., Schmidt, Marjanka K., Hooning, Maartje J., Jager, Agnes
Publicado 2020

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020)...

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A.M., van Doorn, Helena C., Schmidt, Marjanka K., Hooning, Maartje J., Jager, Agnes
Publicado 2020

Factors Predicting 30-Day Grade IIIa–V Clavien–Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer:...

por Kengsakul, Malika, Nieuwenhuyzen-de Boer, Gatske M., Udomkarnjananun, Suwasin, Kerr, Stephen J., van Doorn, Helena C., van Beekhuizen, Heleen J.
Publicado 2022

Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study

por van Doorn, Helena C., Oonk, Maaike H. M., Fons, Guus, Gaarenstroom, Katja N., de Hullu, Joanne, van Rosmalen, Joost, van Beekhuizen, Heleen J.
Publicado 2022

A sexual rehabilitation intervention for women with gynaecological cancer receiving radiotherapy (SPARC study): design of a multicentre randomized controlled trial

por Suvaal, Isabelle, Hummel, Susanna B., Mens, Jan-Willem M., van Doorn, Helena C., van den Hout, Wilbert B., Creutzberg, Carien L., ter Kuile, Moniek M.
Publicado 2021

Patient-Reported Mobility, Physical Activity, and Bicycle Use after Vulvar Carcinoma Surgery

por van de Berg, Nick J., van Beurden, Franciscus P., Wendel-Vos, G. C. Wanda, Duijvestijn, Marjolein, van Beekhuizen, Heleen J., Maliepaard, Marianne, van Doorn, Helena C.
Publicado 2023

Malignant Struma Ovarii: Good Response after Thyroidectomy and (131)I Ablation Therapy

por Janszen, Erica W.M., van Doorn, Helena C., Ewing, Patricia C., de Krijger, Ronald R., de Wilt, Johannes H.W., Kam, Boen L.R., de Herder, Wouter W.
Publicado 2008

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy

por Kortekaas, Kim E, Santegoets, Saskia J, Tas, Liselotte, Ehsan, Ilina, Charoentong, Pornpimol, van Doorn, Helena C, van Poelgeest, Mariette I E, Mustafa, Dana A M, van der Burg, Sjoerd H
Publicado 2021

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers

por Eikenboom, Ellis L., van Doorn, Helena C., Dinjens, Winand N. M., Dubbink, Hendrikus J., Geurts-Giele, Willemina R. R., Spaander, Manon C. W., Tops, Carli M. J., Wagner, Anja, Goverde, Anne
Publicado 2021

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing

por Harmsen, Marline G., Steenbeek, Miranda P., Hoogerbrugge, Nicoline, van Doorn, Helena C., Gaarenstroom, Katja N., Vos, M. Caroline, Massuger, Leon F.A.G., de Hullu, Joanne A., Hermens, Rosella P.M.G.
Publicado 2017

Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients

por Nieuwenhuyzen-de Boer, Gatske M., Aamran, Hanane, van den Berg, Caroline B., Willemsen, Sten, Piek, Jurgen M. J., Reesink-Peters, Nathalie, Maliepaard, Marianne, van Doorn, Helena C., Polinder, Suzanne, van Beekhuizen, Heleen J.
Publicado 2023

High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status

por Kortekaas, Kim E., Santegoets, Saskia J., Abdulrahman, Ziena, van Ham, Vanessa J., van der Tol, Marij, Ehsan, Ilina, van Doorn, Helena C., Bosse, Tjalling, van Poelgeest, Mariëtte I. E., van der Burg, Sjoerd H.
Publicado 2019

Nuclear factor IB is downregulated in vulvar squamous cell carcinoma (VSCC): Unravelling differentially expressed genes in VSCC through gene expression dataset analysis

por Dasgupta, Shatavisha, Ewing-Graham, Patricia C., Van Den Bosch, Thierry P.P., Swagemakers, Sigrid M.A., Santegoets, Lindy A.M., Van Doorn, Helena C., Van Der Spek, Peter J., Koljenović, Senada, Van Kemenade, Folkert J.
Publicado 2021

Evaluation of Immunohistochemical Markers, CK17 and SOX2, as Adjuncts to p53 for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia (dVIN)

por Dasgupta, Shatavisha, Koljenović, Senada, van den Bosch, Thierry P. P., Swagemakers, Sigrid M. A., van der Hoeven, Nick M. A., van Marion, Ronald, van der Spek, Peter J., van Doorn, Helena C., van Kemenade, Folkert J., Ewing-Graham, Patricia C.
Publicado 2021

Exploring Differentially Methylated Genes in Vulvar Squamous Cell Carcinoma

por Dasgupta, Shatavisha, Ewing-Graham, Patricia C., Swagemakers, Sigrid M. A., van den Bosch, Thierry P. P., Atmodimedjo, Peggy N., Verbiest, Michael M. P. J., de Haan, Marit, van Doorn, Helena C., van der Spek, Peter J., Koljenović, Senada, van Kemenade, Folkert J.
Publicado 2021